BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16868978)

  • 1. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
    Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
    Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.
    Zhang W; Gao F; Lu D; Sun N; Yin X; Jin M; Liu Y
    Front Med; 2016 Mar; 10(1):76-84. PubMed ID: 26620053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
    Vlachoyiannopoulos PG; Routsias JG
    J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
    Pennings MT; Derksen RH; van Lummel M; Adelmeijer J; VanHoorelbeke K; Urbanus RT; Lisman T; de Groot PG
    J Thromb Haemost; 2007 Feb; 5(2):369-77. PubMed ID: 17096706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.
    Rahgozar S; Giannakopoulos B; Yan X; Wei J; Cheng Qi J; Gemmell R; Krilis SA
    Arthritis Rheum; 2008 Apr; 58(4):1146-55. PubMed ID: 18383370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
    Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.
    Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y
    Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
    Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein Ibα clustering induces macrophage-mediated platelet clearance in the liver.
    Yan R; Chen M; Ma N; Zhao L; Cao L; Zhang Y; Zhang J; Yu Z; Wang Z; Xia L; Ruan C; Dai K
    Thromb Haemost; 2015 Jan; 113(1):107-17. PubMed ID: 25231551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between GPIbalpha and FcgammaIIA receptor in human platelets.
    Sun B; Li J; Kambayashi Ji
    Biochem Biophys Res Commun; 1999 Dec; 266(1):24-7. PubMed ID: 10581159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor.
    Strassel C; Pasquet JM; Alessi MC; Juhan-Vague I; Chambost H; Combrié R; Nurden P; Bas MJ; De La Salle C; Cazenave JP; Lanza F; Nurden AT
    Biochemistry; 2003 Apr; 42(15):4452-62. PubMed ID: 12693941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
    Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
    J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution.
    Tincani A; Spatola L; Prati E; Allegri F; Ferremi P; Cattaneo R; Meroni P; Balestrieri G
    J Immunol; 1996 Dec; 157(12):5732-8. PubMed ID: 8955227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.